Ann: US grants fund PAT-DX1 and PAT-DX1-NP targeting brain tumors, page-33

I wont argue about funding but my estimates is around $15m going by other similar trials..

I would say a re-rate will definitely come before money needed as PAB are good at pumping, the last raising is the best example...Bank full and SP from the highs after the raising now down over 70%, bit even if this doubled most long termers who tipped in last time would still be in the red...

Im not saying i wouldn't tip in for the trial, what i am saying is they should of done a much better job of trying to form a higher base for this to bounce off and keep long termers within reach of good gains instead of having to buy all the way down to keep their investment intact